GRAMEGNA, ANDREA
GRAMEGNA, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis
2025 A. Gramegna, G. Cimino, M. Cipolli, G. Gandini, M.A. Calderazzo, A. Profiti, F. Piedepalumbo, F. Blasi
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
2025 C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
2024 A. Gramegna, C. Addy, L. Allen, E. Bakkeheim, C. Brown, T. Daniels, G. Davies, J.C. Davies, K. De Marie, D. Downey, I. Felton, S. Hafkemeyer, S. Hamouda, V. Kendall, U. Lindberg, M. Macek, S. Mayell, O. Pearlsman, M.S. Schechter, L. Salvatori, D. Sands, C. Schwarz, M. Shteinberg, J. Taylor, J.L. Taylor-Cousar, D. Taylor-Robinson, B. Watkins, M. Verkleij, A. Bevan, C. Castellani, P. Drevinek, S. Gartner, E. Lammertyn, E.(.C. Landau, P.G. Middleton, B.J. Plant, A.R. Smyth, S. van Koningsbruggen-Rietschel, P. Burgel, K.W. Southern
Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions
2024 F. Ciciriello, F. Panariello, P. Medino, A. Biffi, F. Alghisi, C. Rosazza, P. Annunziata, V. Bouchè, A. Grimaldi, D. Guidone, A. Venturini, G. Alicandro, M. Oggioni, P. Cerino, G. Paiola, A. Gramegna, A. Fiocchi, A. Bandera, V. Lucidi, D. Cacchiarelli, L.J.V. Galietta, C. Colombo
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
2024 A. Gramegna, G. Alicandro, C. Premuda, F. Lucca, L. Pinali, M. Retucci, V. Vespro, M.C. Andrisani, G. Carraffiello, F. Amati, S. Volpi, S. Aliberti, M. Cipolli, F. Blasi
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders
2024 F. Amati, G. Leonardi, M. Contarini, L.C. Morlacchi, A. Stainer, G. Pizzamiglio, S. Aliberti, F. Blasi, A. Gramegna
Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy
2024 A. Gramegna, M. Ruscica, G. Leonardi, C. Macchi, I. Fichtner, G. Putti, M.C. Schianca, L. Terranova, G. Alicandro, F. Blasi
Standards of care and educational gaps in adult cystic fibrosis units: a European Respiratory Society survey
2024 A. Felipe Montiel, A. Álvarez Fernández, M. Culebras Amigo, F. Blasi, A. Gramegna, S. Elborn, A. Horsley, S. Madge, D. Stolz, N. Tabin, C. Pannetier, E. Polverino
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study
2024 C. Blardone, S. Gambazza, A. Mariani, R. Galgani, A. Brivio, R.M. Nobili, C. Rizza, A.L. Tutino, A. Gramegna, V. Daccò, M. Contarini, F. Blasi, D. Laquintana
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
2024 G. Bongiovanni, A. Tonutti, A. Stainer, M. Nigro, D.L. Kellogg, A. Nambiar, A. Gramegna, M. Mantero, A. Voza, F. Blasi, S. Aliberti, F. Amati
Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis
2024 N.I. Lorè, A. Gramegna, S. de Pretis, F. Di Marco, F. Giannese, F. Saliu, C. Oneto, M. Contarini, L. Cariani, F. Blasi, D.M. Cirillo
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
2024 A. Gramegna, S. Aliberti, A. Amorim, F. Blasi, S. Bourke, P. Burgel, F. Diamantea, I. Durieu, L. Fila, R.M.G. Moreno, B. Messore, E. Pokojová, G. Taccetti, S. Verhulst, A.V. Dugac, S. Wege, A. Duff, K.W. Southern, C. Castellani
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kγ for therapeutic cAMP modulation in pulmonary cells
2024 A. Della Sala, L. Tasca, C. Butnarasu, V. Sala, G. Prono, A. Murabito, O.V. Garbero, E. Millo, L. Terranova, F. Blasi, A. Gramegna, S. Aliberti, A. Massarotti, S. Visentin, E. Hirsch, A. Ghigo
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
2024 A. Lombardi, S. Villa, M. Colaneri, G. Scaglione, F. Bai, B. Varisco, V. Bono, A. Vena, C. Dentone, C. Russo, M. Tettamanti, G. Renisi, G. Viero, C. Azzarà, M. Mantero, F. Peyvandi, M. Bassetti, G. Marchetti, A. Muscatello, A. Nobili, A. Gori, A. Bandera, S. Bosari, L. Scudeller, G. Fusetti, L. Rusconi, S. Dell’Orto, D. Prati, L. Valenti, S. Giovannelli, M. Manunta, G. Lamorte, F. Ferarri, D. Mangioni, L. Alagna, G. Bozzi, A. Lombardi., R. Ungaro, G. Ancona, M. Mussa, B.V. Mariani, M. Bolis, N. Iannotti, S. Ludovisi, A. Comelli, S. Biscarini, V. Castelli, E. Palomba, M. Fava, C.A. Peri, P. Saltini, T. Itri, V. Ferroni, V. Pastore, R. Massafra, A. Liparoti, T. Muheberimana, A. Giommi, R. Bianco, G.E. Chitani, C. Bobbio, I. De Matteis, A.B. Bonomi, R. Gualtierotti, B. Ferrari, R. Rossio, N. Boasi, E. Pagliaro, C. Massimo, M. De Caro, A. Giachi, N. Montano, B. Vigone, C. Bellocchi, A. Carandina, E. Fiorelli, V. Melli, E. Tobaldini, F. Blasi, S. Aliberti, M. Spotti, L. Terranova, S. Misuraca, A. D’Adda, S. Della Fiore, M. Di Pasquale, M. Contarini, M. Ori, L. Morlacchi, V. Rossetti, A. Gramegna, M. Pappalettera, M. Cavallini, A. Buscemi, M. Vicenzi, I. Rota, G. Costantino, M. Solbiati, L. Furlan, M. Mancarella, G. Colombo, G. Colombo, A. Fanin, M. Passarella, V. Monzani, C. Canetta, A. Rovellini, L. Barbetta, F. Billi, C. Folli, S. Accordino, D. Maira, C.M. Hu, I. Motta, N. Scaramellini, A.L. Fracanzani, R. Lombardi, A. Cespiati, M. Cesari, T. Lucchi, M. Proietti, L. Calcaterra, C. Mandelli, C. Coppola, A. Cerizza, A.M. Pesenti, G. Grasselli, A. Galazzi, I. Monti, A.A. Galbussera, E. Crisafulli, D. Girelli, A. Maroccia, D. Gabbiani, F. Busti, A. Vianello, M. Biondan, F. Sartori, P. Faverio, A. Pesci, S. Zucchetti, P. Bonfanti, M. Rossi, I. Beretta, A. Spolti, S. Harari, D. Elia, R. Cassandro, A. Caminati, F. Cipollone, M.T. Guagnano, D. D’Ardes, I. Rossi, F. Vezzani, A. Spanevello, F. Cherubino, D. Visca, M. Contoli, A. Papi, L. Morandi, N. Battistini, G.L. Moreo, P. Iannuzzi, D. Fumagalla, S. Leone
Diagnostic delay in bronchiectasis: an Italian perspective
2024 C. Chessari, E. Simonetta, F. Amati, M. Nigro, A. Stainer, G. Sotgiu, M. Puci, A. Gramegna, F. Blasi, L.C. Morlacchi, A.A.M.D. Buscemi, V. Conio, V. Sanci, A.G. Corsico, P. Faverio, W. Michalak, F. Luppi, C. Crimi, C. Vancheri, R. Campisi, M.R. Vulpi, G.E. Carpagnano, M. Cicchetti, K. Sekretna, N. Scichilone, S. Battaglia, S. Aliberti
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis
2024 A. Gramegna, I. Barone, G. Alicandro, G. Sotgiu, A. Bellofiore, C. Colombo, A. Arcadu, M. Ori, F. Blasi, E. Simonetta, M. Vicenzi, S. Aliberti, F. Blasi
Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor Therapy
2024 V. Daccò, A. Gramegna, C. Rosazza, A. Mariani, A. Biffi, C. Lanfranchi, L. Zazzeron, F. Bellante, F. Blasi, G. Alicandro
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
2024 G. Alicandro, A. Gramegna, F. Bellino, S.C. Sciarrabba, C. Lanfranchi, M. Contarini, M. Retucci, V. Daccò, F. Blasi
Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report
2024 M.S. Silani, E. Simonetta, A. Gramegna, A. De Angelis, F. Blasi, S. Aliberti
Comments on PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV
2023 A. Lombardi, A. Gramegna, P. Gruarin, R. Grifantini, A. Gori, F. Blasi, A. Bandera